Researchers tracked spending on drinks while out and found a sharp drop among people taking GLP-1 medications.
Recap by typeshit. Post by Facebook on Facebook.
Popular Mechanics traces how her 1980s work at Mass General showed GLP-1 triggers insulin release. Gallup now puts GLP-1 weight loss use at about 11% of Americans.
Barzilai highlights trial results on retatrutide in adults with sleep apnea and obesity or overweight, a new use being tested for Lilly's drug.
The Washington meeting runs November 14 to 17, with primary REDEFINE 9 results and pediatric semaglutide research for kids 6 to under 12.
He says this average comes from his own clinical experience, adding that some strong responders drop more than 10 kg. A personal observation, not trial data.
The hosts point to rapid, significant weight loss as a known trigger for hair shedding, separate from the medication itself.
On Business Insider's The Long Play, Reitano walks through nine years of strategy shifts that moved Ro from telehealth toward GLP-1 care.
Loading…